Takasugi BJ - Search Results

1

Chemotherapy and radiation therapy before transhiatal esophagectomy for esophageal carcinoma.

Orringer MB, Forastiere AA, Perez-Tamayo C, Urba S, Takasugi BJ, Bromberg J. Orringer MB, et al. Among authors: takasugi bj. Ann Thorac Surg. 1990 Mar;49(3):348-54; discussion 354-5. doi: 10.1016/0003-4975(90)90237-z. Ann Thorac Surg. 1990. PMID: 2106845 Review.

2

Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus.

Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Husted S, Takasugi BJ, Zahurak M. Forastiere AA, et al. Among authors: takasugi bj. J Clin Oncol. 1990 Jan;8(1):119-27. doi: 10.1200/JCO.1990.8.1.119. J Clin Oncol. 1990. PMID: 2295902

3

Phase II trial of N-methylformamide in advanced head and neck cancer.

Vogel WC, Forastiere AA, Natale RB, Takasugi BJ, Schnur G. Vogel WC, et al. Among authors: takasugi bj. Invest New Drugs. 1987;5(2):203-6. doi: 10.1007/BF00203547. Invest New Drugs. 1987. PMID: 3654153 Free article.

4

A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck.

Forastiere AA, Natale RB, Takasugi BJ, Goren MP, Vogel WC, Kudla-Hatch V. Forastiere AA, et al. Among authors: takasugi bj. J Clin Oncol. 1987 Feb;5(2):190-6. doi: 10.1200/JCO.1987.5.2.190. J Clin Oncol. 1987. PMID: 3543242

5

A phase II trial of cisplatin and methylglyoxal bis-guanylhydrazone (MGBG) in recurrent squamous cell carcinoma of the head and neck.

Takasugi BJ, Perry DJ, Wheeler RH, Forastiere AA. Takasugi BJ, et al. Am J Clin Oncol. 1986 Aug;9(4):299-301. doi: 10.1097/00000421-198608000-00004. Am J Clin Oncol. 1986. PMID: 3751967

6

High-dose cisplatin in advanced head and neck cancer.

Forastiere AA, Takasugi BJ, Baker SR, Wolf GT, Kudla-Hatch V. Forastiere AA, et al. Among authors: takasugi bj. Cancer Chemother Pharmacol. 1987;19(2):155-8. doi: 10.1007/BF00254569. Cancer Chemother Pharmacol. 1987. PMID: 3568273 Free article.

7

Five-day schedule of vinzolidine, an oral vinca alkaloid, in a variety of tumors.

Takasugi BJ, Robertone AB, Salmon SE, Jones SE, Alberts DS. Takasugi BJ, et al. Invest New Drugs. 1984;2(4):387-90. doi: 10.1007/BF00171590. Invest New Drugs. 1984. PMID: 6096287

8

Chemotherapy of advanced non-small cell lung cancer. A review.

Takasugi BJ, Miller TP. Takasugi BJ, et al. Invest New Drugs. 1984;2(3):339-47. doi: 10.1007/BF00175389. Invest New Drugs. 1984. PMID: 6392149 Review. No abstract available.

9

Relation of in vitro colony survival to clinical response in a prospective trial of single-agent chemotherapy for metastatic melanoma.

Meyskens FL Jr, Loescher L, Moon TE, Takasugi B, Salmon SE. Meyskens FL Jr, et al. J Clin Oncol. 1984 Nov;2(11):1223-8. doi: 10.1200/JCO.1984.2.11.1223. J Clin Oncol. 1984. PMID: 6387058 Free article. Clinical Trial.

10

Antitumor activity of vinzolidine in the human tumor clonogenic assay and comparison with vinblastine.

Takasugi BJ, Salmon SE, Nelson RL, Young L, Liu RM. Takasugi BJ, et al. Invest New Drugs. 1984;2(1):49-53. doi: 10.1007/BF00173786. Invest New Drugs. 1984. PMID: 6469498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Search Page

Filters